SureNano Closes Financing
SureNano Science (OTCQB:SURNF) has completed a private placement financing, raising $245,000 through the issuance of 2,450,000 common shares at $0.10 per share. The financing includes $85,000 in debt conversion and $160,000 in cash proceeds.
Company President Charles Malette participated significantly, investing $110,000 in cash and converting $85,000 in debt. Following the transaction, Malette will own 9,621,600 shares, representing 40% ownership of the company. The funds will be used for operating expenses and working capital.
SureNano Science (OTCQB:SURNF) ha concluso una private placement, raccogliendo $245,000 tramite l'emissione di 2,450,000 azioni ordinarie a $0.10 per azione. Il finanziamento comprende $85,000 in conversione di debito e $160,000 in contanti.
Il presidente della società, Charles Malette, ha partecipato in modo significativo, investendo $110,000 in contanti e convertendo $85,000 in debito. A seguito della transazione, Malette possiederà 9,621,600 azioni, rappresentando il 40% della proprietà della società. I fondi verranno utilizzati per spese operative e capitale circolante.
SureNano Science (OTCQB:SURNF) ha completado una financiación mediante colocación privada, obteniendo $245,000 a través de la emisión de 2,450,000 acciones ordinarias a $0.10 por acción. La financiación incluye $85,000 en conversión de deuda y $160,000 en ingresos en efectivo.
El presidente de la empresa, Charles Malette, participó de forma significativa, invirtiendo $110,000 en efectivo y convirtiendo $85,000 en deuda. Tras la operación, Malette poseerá 9,621,600 acciones, que representan el 40% de la propiedad de la empresa. Los fondos se utilizarán para gastos operativos y capital de trabajo.
SureNano Science (OTCQB:SURNF)는 비공개 배정 자금 조달을 완료했고, $245,000를 주당 $0.10에 2,450,000주 일반주를 발행하여 마련했습니다. 자금조달에는 $85,000의 부채전환과 $160,000의 현금수익이 포함됩니다.
회사 사장 찰스 말레트가 상당히 참여하여 $110,000의 현금투자와 $85,000의 부채전환을 수행했습니다. 거래 후 말레트는 9,621,600주를 소유하게 되며, 이는 회사의 40% 소유권에 해당합니다. 자금은 운영비 및 운전자본으로 사용될 예정입니다.
SureNano Science (OTCQB:SURNF) a terminé une placement privé, levant $245,000 par l’émission de 2,450,000 actions ordinaires à $0,10 par action. Le financement comprend $85,000 en conversion de dette et $160,000 en produit de trésorerie.
Le président de l'entreprise, Charles Malette, a participé de manière significative, en investissant $110,000 en espèces et en convertissant $85,000 de dette. À l’issue de l’opération, Malette détiendra 9,621,600 actions, représentant 40% de la propriété de la société. Les fonds seront utilisés pour les dépenses opérationnelles et le fonds de roulement.
SureNano Science (OTCQB:SURNF) hat eine private Platzierung abgeschlossen und $245,000 durch die Ausgabe von 2,450,000 Stammaktien zu $0,10 pro Aktie aufgenommen. Die Finanzierung umfasst $85,000 in Schuldumwandlung und $160,000 an Barmitteln.
Unternehmenspräsident Charles Malette hat sich wesentlich beteiligt, indem er $110,000 in bar investierte und $85,000 in Schulden umwandelte. Nach der Transaktion wird Malette 9,621,600 Aktien besitzen, was 40% des Unternehmens entspricht. Die Mittel werden für Betriebsausgaben und Working Capital verwendet.
SureNano Science (OTCQB:SURNF) أنجزت تمويلاً خاصاً عبر الاكتتاب الخاص، حيث جُمعت $245,000 من خلال إصدار 2,450,000 سهماً عائداً بسعر $0.10 للسهم. يشمل التمويل $85,000 في تحويل الدين و $160,000 في العائد نقداً.
شارك رئيس الشركة تشارلز ماليت بشكل كبير، باستثمار $110,000 نقداً وتحويل $85,000 من الدين. عقب الصفقة، سيملك ماليت 9,621,600 سهماً، occupying 40% من ملكية الشركة. ستستخدم الأموال في النفقات التشغيلية ورأس المال العامل.
SureNano Science (OTCQB:SURNF) 已完成私募融资，通过发行 2,450,000股普通股，价格为每股 $0.10，募集 $245,000。融资包括 $85,000 的债务转换 和 $160,000 的现金收益。
公司总裁 Charles Malette 参与显著，投資 $110,000 现金，并将 $85,000 的债务转换。交易完成后，Malette 将拥有 9,621,600 股，占公司 40% 的所有权。资金将用于经营费用和营运资金。
- Successful completion of $245,000 financing
- Strong insider participation with President investing $195,000 total
- Reduction of $85,000 in company debt through conversion
- Funds secured for operating expenses and working capital
- Significant share dilution at $0.10 per share
- Increased insider control with President now owning 40% of shares
- Small financing amount may indicate limited investor interest
Vancouver, British Columbia--(Newsfile Corp. - September 19, 2025) - SURENANO SCIENCE LTD. (CSE: SURE) (OTCQB: SURNF) (the "Company" or "SureNano") announces that it has closed a private placement financing of 2,450,000 common shares at a price of
The Company intends to use the cash proceeds for operating expenses, including legal and audit fees and general working capital. No part of the proceeds will be used in connection with investor relations activities. All securities issued in the private placement will be subject to a four month and a day hold period.
A related party, Charles Malette, participated in the private placement, purchasing shares for
About SureNano Science Ltd.:
The business of SureNano Science Ltd. is the sale and distribution of the SureNano™ surfactant, which is a ready-to-mix food grade compound that provides the base for high performance nanoemulsions to create incredibly homogeneous and stable products while maximizing bioavailability, clarity, and taste. The Company has an exclusive license to distribute the SureNanoTM surfactant within Canada; Oklahoma, USA; and Colorado, USA.
ON BEHALF OF SURENANO SCIENCE LTD.
"Charles MaLette"
CEO, President, Director & Secretary
T: 604-428-5171
E: info@surenano.com
Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of SureNano. Forward-looking information is based on certain key expectations and assumptions made by the management of SureNano. In some cases, you can identify forward-looking statements by the use of words such as "will," "may," "would," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "could" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Although SureNano believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because SureNano can give no assurance that they will prove to be correct.
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/267243
FAQ
How much did SureNano (SURNF) raise in their September 2025 private placement?
What is the price per share for SureNano's 2025 private placement?
How many shares will Charles Malette own after SureNano's private placement?
What will SureNano (SURNF) use the financing proceeds for?
What is the hold period for SureNano's private placement shares?
